At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
Magnetotherapy device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Magnetotherapy in Hand Erosive Osteoarthritis. A Randomized Clinical Trial.
In Brief
A clinical study evaluating Magnetotherapy device and Placebo for Musculoskeletal Disease and 2 related conditions. Completed, enrolled 19 participants.
Detailed Summary
Erosive arthritis (EA) is an unusual pathology. There is no definitive treatment and the conventional one has little efficacy. Despite using magnetotherapy (MGT) as a treatment, there is no evidence supporting its use.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
Primary CompletionMay 2017
First PostedJan 2019
Study CompletionFeb 2019
TodayJul 2026
First PostedJan 15, 2019
Enrollment StartJan 2, 2016
Primary CompletionMay 1, 2017
Study CompletionFeb 2, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.5 years ago
Interventions
Magnetotherapy devicedevice
Use of magnetotherapy device 15 consecutive working days in elegible patients with erosive hand osteoarthritis.
Placebodevice
Use of unplugged magnetotherapy device 15 consecutive working days in elegible patients with erosive hand osteoarthritis.